Filing Flows › Comparisons › ZVRA vs AKBA
Zevra Therapeutics vs Akebia Therapeutics: ZVRA and AKBA compared
Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $36.9M for Akebia Therapeutics (Q3 2026). Zevra Therapeutics is growing faster (+45% against -37% a year earlier). Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -31.1%.
Where the money goes: ZVRA and AKBA
Zevra Therapeutics (ZVRA) · Q3 2026
Zevra Therapeutics, Q3 2026: revenue $37.8M (+45% year over year), operating margin 30.7%, net earnings $19.2M, operating cash flow $10.0M. The chart follows the revenue to costs, profit and cash.
Akebia Therapeutics (AKBA) · Q3 2026
Akebia Therapeutics, Q3 2026: revenue $36.9M (-37% year over year), operating margin -31.1%, net loss $14.4M, operating cash flow $2.3M. The chart follows the revenue to costs, profit and cash.
| Zevra Therapeutics (ZVRA) | Akebia Therapeutics (AKBA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $37.8M | $36.9M |
| Revenue growth, Y/Y | +45% | -37% |
| Operating margin | 30.7% | -31.1% |
| Net earnings | $19.2M | −$14.4M |
| Net margin | 50.9% | -38.9% |
| Operating cash flow | $10.0M | $2.3M |
| Free cash flow | $9.8M | $1.6M |
| Market value | $636M | — |
| P/E | 8.5× | — |
| Analysts’ mean target | $25.25 | — |
Where the revenue comes from
Akebia Therapeutics
- Product revenue, net: $34.8M (94%)
- License, collaboration and other revenue: $2.1M (6%)
Questions
Which is bigger, Zevra Therapeutics or Akebia Therapeutics?
Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $36.9M for Akebia Therapeutics (Q3 2026).
Is Zevra Therapeutics or Akebia Therapeutics growing faster?
Zevra Therapeutics is growing faster (+45% against -37% a year earlier).
Which is more profitable, Zevra Therapeutics or Akebia Therapeutics?
Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -31.1%.
More: Zevra Therapeutics earnings · how Zevra Therapeutics makes money · Akebia Therapeutics earnings · how Akebia Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.